126 related articles for article (PubMed ID: 10391875)
1. Long-term persistence of immunoglobulin A (IgA) and IgM antibodies against human cytomegalovirus in solid-organ transplant recipients.
Eing BR; Baumeister HG; Kuehn JE; May G
Clin Diagn Lab Immunol; 1999 Jul; 6(4):621-3. PubMed ID: 10391875
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.
Mengelle C; Pasquier C; Rostaing L; Sandres-Sauné K; Puel J; Berges L; Righi L; Bouquies C; Izopet J
J Med Virol; 2003 Feb; 69(2):225-31. PubMed ID: 12683412
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea.
La Y; Kwon DE; Yoo SG; Lee KH; Han SH; Song YG
BMC Infect Dis; 2019 Nov; 19(1):948. PubMed ID: 31703564
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection.
Freymuth F; Gennetay E; Petitjean J; Eugene G; Hurault de Ligny B; Ryckelynck JP; Legoff C; Hazera P; Bazin C
J Clin Microbiol; 1994 Jun; 32(6):1614-8. PubMed ID: 8077418
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
9. Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients.
Weber B; Nestler U; Ernst W; Rabenau H; Braner J; Birkenbach A; Scheuermann EH; Schoeppe W; Doerr HW
J Med Virol; 1994 Jun; 43(2):187-93. PubMed ID: 8083668
[TBL] [Abstract][Full Text] [Related]
10. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients.
Müller TF; Gicklhorn D; Jungraithmayr T; Eickmann M; Lange H; Radsak K; Reschke M
J Clin Virol; 2002 Feb; 24(1-2):45-56. PubMed ID: 11744428
[TBL] [Abstract][Full Text] [Related]
11. Monitoring for cytomegalovirus infection in organ transplant recipients: analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes.
Gaeta A; Nazzari C; Angeletti S; Lazzarini M; Mazzei E; Mancini C
J Med Virol; 1997 Nov; 53(3):189-95. PubMed ID: 9365881
[TBL] [Abstract][Full Text] [Related]
12. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
[TBL] [Abstract][Full Text] [Related]
14. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
[TBL] [Abstract][Full Text] [Related]
15. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
[TBL] [Abstract][Full Text] [Related]
17. Significance of human cytomegalovirus DNA detection in immunocompromised heart transplant patients.
Wolff C; Skourtopoulos M; Hörnschemeyer D; Wolff D; Körner M; Huffert F; Körfer R; Kleesier K
Transplantation; 1996 Mar; 61(5):750-7. PubMed ID: 8607179
[TBL] [Abstract][Full Text] [Related]
18. Improvement of serological diagnosis of human cytomegalovirus infection in renal transplant recipients by testing for specific immunoglobulin E by ELISA.
Weber B; Stemmler A; Ernst W; Scheuerman EH; Braun W; Doerr HW
Infection; 1993; 21(3):158-63. PubMed ID: 8396070
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.
Brytting M; Xu W; Wahren B; Sundqvist VA
J Clin Microbiol; 1992 Aug; 30(8):1937-41. PubMed ID: 1323573
[TBL] [Abstract][Full Text] [Related]
20. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
